Refractory Kimura's disease accompanied with prurigo responding to dupilumab administration: A case report

Kimura's disease is refractory and sometimes has prurigo as a comorbidity. This report shows a case of Kimura's disease accompanied by prurigo and successfully treated both with dupilumab. Dupilumab might be considered for Kimura's disease with prurigo, which is resistant to conventio...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cutaneous immunology and allergy 2023-08, Vol.6 (4), p.134-135
Main Authors: Fukami, Fumie, Koike, Yuta, Murota, Hiroyuki
Format: Article
Language:English
Subjects:
Biopsy
Case reports
Dermatitis
Disease
Monoclonal antibodies
Skin
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4538-5c5d755b122b4a6592f66d093829de492e40eea6d26500cbf9313c3b51c9d5103
container_end_page 135
container_issue 4
container_start_page 134
container_title Journal of cutaneous immunology and allergy
container_volume 6
creator Fukami, Fumie
Koike, Yuta
Murota, Hiroyuki
description Kimura's disease is refractory and sometimes has prurigo as a comorbidity. This report shows a case of Kimura's disease accompanied by prurigo and successfully treated both with dupilumab. Dupilumab might be considered for Kimura's disease with prurigo, which is resistant to conventional treatments.
doi_str_mv 10.1002/cia2.12298
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4f8b2a60e122485292f8f1ba5affa62c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4f8b2a60e122485292f8f1ba5affa62c</doaj_id><sourcerecordid>2844578917</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4538-5c5d755b122b4a6592f66d093829de492e40eea6d26500cbf9313c3b51c9d5103</originalsourceid><addsrcrecordid>eNp9kU1LxDAQhosouKgXf0HAgyCsJmnSbbwtix-LgiB6DtN8rFm2TZ20LPvv7VoRTx7ChOGZ953hzbJzRq8ZpfzGBODXjHNVHmQTLmdiKqTKD__8j7OzlNZ0gPcv55Ns_eo8guki7shTqHuEy0RsSA6SI2BMrFtogrNkG7oP0mKPYRUJutTGxoZmRbpIbN-GTV9DRcDWoQmpQ-hCbG7JnJi9Dro2YneaHXnYJHf2U0-y9_u7t8Xj9PnlYbmYP0-NkHk5lUbamZTVcEgloJCK-6KwVOUlV9YJxZ2gzkFheSEpNZVXOctNXklmlJWM5ifZctS1Eda6xVAD7nSEoL8bEVcasAtm47TwZcWhoG4wE6Xkg1fpWQUSvIeCm0HrYtRqMX72LnV6HXtshvU1L4WQs1Kx2UBdjZTBmBI6_-vKqN5Ho_fR6O9oBpiN8DZs3O4fUi-Wcz7OfAEbJ5Am</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844578917</pqid></control><display><type>article</type><title>Refractory Kimura's disease accompanied with prurigo responding to dupilumab administration: A case report</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content (ProQuest)</source><creator>Fukami, Fumie ; Koike, Yuta ; Murota, Hiroyuki</creator><creatorcontrib>Fukami, Fumie ; Koike, Yuta ; Murota, Hiroyuki</creatorcontrib><description>Kimura's disease is refractory and sometimes has prurigo as a comorbidity. This report shows a case of Kimura's disease accompanied by prurigo and successfully treated both with dupilumab. Dupilumab might be considered for Kimura's disease with prurigo, which is resistant to conventional treatments.</description><identifier>ISSN: 2574-4593</identifier><identifier>EISSN: 2574-4593</identifier><identifier>DOI: 10.1002/cia2.12298</identifier><language>eng</language><publisher>Tokyo: Frontiers Media SA</publisher><subject>Biopsy ; Case reports ; Dermatitis ; Disease ; Monoclonal antibodies ; Skin</subject><ispartof>Journal of cutaneous immunology and allergy, 2023-08, Vol.6 (4), p.134-135</ispartof><rights>2023 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of The Japanese Society for Cutaneous Immunology and Allergy.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4538-5c5d755b122b4a6592f66d093829de492e40eea6d26500cbf9313c3b51c9d5103</cites><orcidid>0000-0002-0450-1377 ; 0000-0002-7921-8840</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2844578917/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2844578917?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,11561,25752,27923,27924,37011,44589,46051,46475,74897</link.rule.ids></links><search><creatorcontrib>Fukami, Fumie</creatorcontrib><creatorcontrib>Koike, Yuta</creatorcontrib><creatorcontrib>Murota, Hiroyuki</creatorcontrib><title>Refractory Kimura's disease accompanied with prurigo responding to dupilumab administration: A case report</title><title>Journal of cutaneous immunology and allergy</title><description>Kimura's disease is refractory and sometimes has prurigo as a comorbidity. This report shows a case of Kimura's disease accompanied by prurigo and successfully treated both with dupilumab. Dupilumab might be considered for Kimura's disease with prurigo, which is resistant to conventional treatments.</description><subject>Biopsy</subject><subject>Case reports</subject><subject>Dermatitis</subject><subject>Disease</subject><subject>Monoclonal antibodies</subject><subject>Skin</subject><issn>2574-4593</issn><issn>2574-4593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU1LxDAQhosouKgXf0HAgyCsJmnSbbwtix-LgiB6DtN8rFm2TZ20LPvv7VoRTx7ChOGZ953hzbJzRq8ZpfzGBODXjHNVHmQTLmdiKqTKD__8j7OzlNZ0gPcv55Ns_eo8guki7shTqHuEy0RsSA6SI2BMrFtogrNkG7oP0mKPYRUJutTGxoZmRbpIbN-GTV9DRcDWoQmpQ-hCbG7JnJi9Dro2YneaHXnYJHf2U0-y9_u7t8Xj9PnlYbmYP0-NkHk5lUbamZTVcEgloJCK-6KwVOUlV9YJxZ2gzkFheSEpNZVXOctNXklmlJWM5ifZctS1Eda6xVAD7nSEoL8bEVcasAtm47TwZcWhoG4wE6Xkg1fpWQUSvIeCm0HrYtRqMX72LnV6HXtshvU1L4WQs1Kx2UBdjZTBmBI6_-vKqN5Ho_fR6O9oBpiN8DZs3O4fUi-Wcz7OfAEbJ5Am</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Fukami, Fumie</creator><creator>Koike, Yuta</creator><creator>Murota, Hiroyuki</creator><general>Frontiers Media SA</general><general>Frontiers Media S.A</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0450-1377</orcidid><orcidid>https://orcid.org/0000-0002-7921-8840</orcidid></search><sort><creationdate>202308</creationdate><title>Refractory Kimura's disease accompanied with prurigo responding to dupilumab administration: A case report</title><author>Fukami, Fumie ; Koike, Yuta ; Murota, Hiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4538-5c5d755b122b4a6592f66d093829de492e40eea6d26500cbf9313c3b51c9d5103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biopsy</topic><topic>Case reports</topic><topic>Dermatitis</topic><topic>Disease</topic><topic>Monoclonal antibodies</topic><topic>Skin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fukami, Fumie</creatorcontrib><creatorcontrib>Koike, Yuta</creatorcontrib><creatorcontrib>Murota, Hiroyuki</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Wiley Online Library Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Directory of Open Access Journals</collection><jtitle>Journal of cutaneous immunology and allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fukami, Fumie</au><au>Koike, Yuta</au><au>Murota, Hiroyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Refractory Kimura's disease accompanied with prurigo responding to dupilumab administration: A case report</atitle><jtitle>Journal of cutaneous immunology and allergy</jtitle><date>2023-08</date><risdate>2023</risdate><volume>6</volume><issue>4</issue><spage>134</spage><epage>135</epage><pages>134-135</pages><issn>2574-4593</issn><eissn>2574-4593</eissn><abstract>Kimura's disease is refractory and sometimes has prurigo as a comorbidity. This report shows a case of Kimura's disease accompanied by prurigo and successfully treated both with dupilumab. Dupilumab might be considered for Kimura's disease with prurigo, which is resistant to conventional treatments.</abstract><cop>Tokyo</cop><pub>Frontiers Media SA</pub><doi>10.1002/cia2.12298</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-0450-1377</orcidid><orcidid>https://orcid.org/0000-0002-7921-8840</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2574-4593
ispartof Journal of cutaneous immunology and allergy, 2023-08, Vol.6 (4), p.134-135
issn 2574-4593
2574-4593
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4f8b2a60e122485292f8f1ba5affa62c
source Wiley-Blackwell Open Access Collection; Publicly Available Content (ProQuest)
subjects Biopsy
Case reports
Dermatitis
Disease
Monoclonal antibodies
Skin
title Refractory Kimura's disease accompanied with prurigo responding to dupilumab administration: A case report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A24%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Refractory%20Kimura's%20disease%20accompanied%20with%20prurigo%20responding%20to%20dupilumab%20administration:%20A%20case%20report&rft.jtitle=Journal%20of%20cutaneous%20immunology%20and%20allergy&rft.au=Fukami,%20Fumie&rft.date=2023-08&rft.volume=6&rft.issue=4&rft.spage=134&rft.epage=135&rft.pages=134-135&rft.issn=2574-4593&rft.eissn=2574-4593&rft_id=info:doi/10.1002/cia2.12298&rft_dat=%3Cproquest_doaj_%3E2844578917%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4538-5c5d755b122b4a6592f66d093829de492e40eea6d26500cbf9313c3b51c9d5103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2844578917&rft_id=info:pmid/&rfr_iscdi=true